Citation Impact
Citing Papers
Osteoporosis
2019 Standout
Regulation of bone morphogenetic protein‐2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells
2004
Who's afraid of the big bad Wolff?: “Wolff's law” and bone functional adaptation
2006 Standout
Systemic manifestations and comorbidities of COPD
2009
Mechanical Strain and Bone Cell Function: A Review
2002
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
The role of magnesium ions in bone regeneration involves the canonical Wnt signaling pathway
2019 Standout
Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity in vitro and in a model of psoriasis
2009
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
The Epidemiology of Distal Radius Fractures
2012 Standout
Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing
2005
Mechanotransduction and the functional response of bone to mechanical strain
1995
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma
2008
Ankylosing spondylitis
2007 Standout
Cellular, molecular, and tissue-level reactions to orthodontic force
2006 Standout
Roadmap to embryo implantation: clues from mouse models
2006 Standout
Estrogen receptor β: the antimechanostat?
2005
Estrogen–progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study
2008
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Monitoring in vivo (re)modeling: A computational approach using 4D microCT data to quantify bone surface movements
2015
P2X7 Nucleotide Receptors Mediate Blebbing in Osteoblasts through a Pathway Involving Lysophosphatidic Acid
2006
Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A2 (iPLA2β)-Null Mice
2008
Bisphosphonates: mechanisms of action.
1996
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody
2013
Psoriasis Pathogenesis and Treatment
2019 Standout
Hesperidin Prevents Androgen Deficiency‐induced Bone Loss in Male Mice
2013
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Nature’s hierarchical materials
2007 Standout
Receptors for Purines and Pyrimidines
2012 Standout
TENSEGRITY: THE ARCHITECTURAL BASIS OF CELLULAR MECHANOTRANSDUCTION
1997 Standout
Bone modeling: biomechanics, molecular mechanisms, and clinical perspectives
2004
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Longitudinal Effects of Teriparatide or Zoledronic Acid on Bone Modeling- and Remodeling-Based Formation in the SHOTZ Study
2017
Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models
2014 Standout
Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study
2017
Calcium phosphates in biomedical applications: materials for the future?
2015 Standout
Orally Bioavailable GSK-3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo
2006
Works of R.B. Setterberg being referenced
Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: Dynamic histomorphometry of changes in bone mass
1993
Lumbar Vertebral Cancellous Bone is Capable of Responding to PGE2 Treatment by Stimulating both Modeling and Remodeling-Dependent Bone Gain in Aged Male Rats
2001
Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain
1999
Early effects of prostaglandin E2 on bone formation and resorption in different bone sites of rats
1995
Erect bipedal stance exercise partially prevents orchidectomy-induced bone loss in the lumbar vertebrae of rats
2000
Estrogen and "Exercise" Have a Synergistic Effect in Preventing Bone Loss in the Lumbar Vertebra and Femoral Neck of the Ovariectomized Rat
2003
Bipedal stance exercise enhances antiresorption effects of estrogen and counteracts its inhibitory effect on bone formation in sham and ovariectomized rats
2001
Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats
2002
Prostaglandin E2 restores cancellous bone to immobilized limb and adds bone to overloaded limb in right hindlimb immobilization rats
1993
Prostaglandin E2 alleviates cyclosporin a-induced bone loss in the rat
1992
Cancellous bone minimodeling-based formation: a Frost, Takahashi legacy.
2008
Effects of prostaglandin E2 and F2α on the skeleton of osteopenic ovariectomized rats
1995
Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats
1995
Simvastatin did not prevent nor restore ovariectomy-induced bone loss in adult rats.
2007
Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
2007